Medicare Enrolled
Dr. Naresh Desireddi, MD
Urology Physician · Lakeway, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Desireddi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desireddi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desireddi
Dr. Naresh Desireddi is an urology physician in Lakeway, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Desireddi performed 8,040 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Desireddi received a total of $6,614 from 51 pharmaceutical and/or device companies across 279 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desireddi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 13% volume in TX
$6,614 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,040
Medicare services
Top 13% in TX for urology physician
Not available
Unique patients (not deduplicated)
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,180 | $19 | $43 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,200 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
686 | $91 | $249 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
466 | $45 | $77 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
459 | $2 | $7 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
400 | $8 | $15 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
261 | $8 | $44 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
252 | $35 | $77 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
199 | $35 | $110 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
140 | $0 | $3 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
108 | $112 | $380 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
93 | $188 | $477 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
84 | $70 | $168 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
79 | $112 | $250 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $136 | $2,000 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
44 | $42 | $82 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
36 | $193 | $508 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
35 | $136 | $336 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
34 | $39 | $211 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
27 | $4 | $122 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
26 | $28 | $76 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
25 | $20 | $191 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
24 | $112 | $433 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
24 | $53 | $156 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
19 | $14 | $289 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
16 | $58 | $194 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
16 | $72 | $390 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $345 | $972 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
14 | $554 | $4,286 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.2% high complexity
64.6% medium
35.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,614
Total received (2018-2024)
Avg $945/year across 7 years
Top 30% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
279
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,199
2023
$653
2022
$555
2021
$891
2020
$249
2019
$1,752
2018
$1,316
Payments by company (2024)
Janssen Biotech, Inc.
$540
Astellas Pharma US Inc
$171
Bayer Healthcare Pharmaceuticals Inc.
$69
Teleflex LLC
$66
PFIZER INC.
$62
Dendreon Pharmaceuticals LLC
$60
Ferring Pharmaceuticals Inc.
$49
Sumitomo Pharma America, Inc.
$49
UROGEN PHARMA, INC.
$43
PROGENICS PHARMACEUTICALS, INC.
$28
ABBVIE INC.
$17
Tolmar, Inc.
$17
AstraZeneca Pharmaceuticals LP
$16
Antares Pharma, Inc.
$13
Top 3 companies account for 65.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,246
NeoTract Inc.
$1,042
Astellas Pharma US Inc
$733
PFIZER INC.
$680
Bayer HealthCare Pharmaceuticals Inc.
$233
Dendreon Pharmaceuticals LLC
$226
Teleflex LLC
$160
Amgen Inc.
$146
AbbVie Inc.
$122
Clarus Therapeutics Inc.
$121
Myovant Sciences Inc.
$115
Boston Scientific Corporation
$110
Antares Pharma, Inc.
$108
Janssen Products, LP
$100
Bayer Healthcare Pharmaceuticals Inc.
$93
Sumitomo Pharma America, Inc.
$91
Ferring Pharmaceuticals Inc.
$90
Endo Pharmaceuticals Inc.
$90
AstraZeneca Pharmaceuticals LP
$82
UROGEN PHARMA, INC.
$75
AbbVie, Inc.
$71
Progenics Pharmaceuticals, Inc.
$65
Abbott Laboratories
$58
Blue Earth Diagnostics Limited
$57
BOSTON SCIENTIFIC CORPORATION
$55
UroGen Pharma, Inc.
$48
UROVANT SCIENCES INC
$36
ABBVIE INC.
$35
TOLMAR Pharmaceuticals, Inc.
$34
Merck Sharp & Dohme LLC
$34
Allergan, Inc.
$34
Travere Therapeutics, Inc.
$32
DENTSPLY IH Inc.
$29
180 Medical, Inc.
$28
PROGENICS PHARMACEUTICALS, INC.
$28
Myriad Genetic Laboratories, Inc.
$27
Novartis Pharmaceuticals Corporation
$27
Allergan Inc.
$26
Retrophin, Inc.
$26
GENZYME CORPORATION
$21
Merck Sharp & Dohme Corporation
$21
Avadel Specialty Pharmaceuticals, LLC
$21
Alexion Pharmaceuticals, Inc.
$21
Hollister Incorporated
$19
Smith+Nephew, Inc.
$19
Tolmar, Inc.
$17
Supernus Pharmaceuticals, Inc.
$15
COLOPLAST CORP
$14
Axonics Modulation Technologies, Inc.
$13
Foundation Medicine, Inc.
$11
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 45.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · Altis · Androgel · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · EDEX · ELIGARD · ERLEADA · Erleada · FOUNDATIONONE · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · General - BPH · JATENZO · JELMYTO · JEVTANA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PROVENGE · PYLARIFY · Proclaim Family of SCS IPGs · Prolaris · Prolia · STRAVIX · SUTENT · TESTOPEL · TLANDO · TOVIAZ · Thiola · ULTOMIRIS · UROLIFT · UroLift · UroLift System · VIAGRA · VaPro Plus Pocket · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
65
County median income
$97,169
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT & WHITE MEDICAL CENTER- AUSTIN
7.6 mi
7.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Desireddi is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Desireddi experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Desireddi performed 3,180 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Desireddi receive payments from pharmaceutical companies?
Yes. Dr. Desireddi received a total of $6,614 from 51 companies across 279 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desireddi's costs compare to other urology physicians in Lakeway?
Dr. Desireddi's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desireddi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Lakeway
Browse urology physicians in Lakeway ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology